salmeterol
Showing 1 - 25 of 57
Replication of the POET-COPD Trial in Healthcare Claims Data
Completed
- Chronic Obstructive Pulmonary Disease
- Salmeterol
- Tiotropium
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 18, 2021
Allergic Rhinitis Trial in Dundee (FLUTICASONE PROPRIONATE, Salmeterol, PLACEBO)
Completed
- Allergic Rhinitis
- FLUTICASONE PROPRIONATE
- +2 more
-
Dundee, United KingdomAsthma and Allergy Research Group, University of Dundee
Oct 10, 2019
Pulmonary Disease, Chronic Obstructive Trial in United States (Tiotropium, Olodaterol, Fluticasone propionate)
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium
- +3 more
-
Jasper, Alabama
- +44 more
Apr 3, 2020
Pulmonary Disease, Chronic Obstructive Trial in Germany (Tiotropium, Olodaterol, Fluticasone propionate)
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium
- +3 more
-
Bamberg, Germany
- +9 more
Jul 9, 2019
Pulmonary Disease, Chronic Obstructive Trial (Tiotropium, Placebo to tiotropium, Salmeterol)
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium
- +3 more
- (no location specified)
Aug 29, 2018
Allergic Asthma Trial in Madison (salmeterol, Fluticasone, Placebo)
Completed
- Allergic Asthma
- salmeterol
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Oct 17, 2017
Pulmonary Disease, Chronic Obstructive Trial in United States (Fluticasone propionate/salmeterol combination product,
Completed
- Pulmonary Disease, Chronic Obstructive
- Fluticasone propionate/salmeterol combination product
- +2 more
-
Jasper, Alabama
- +38 more
Aug 27, 2018
Asthma Trial in United States (salmeterol, beclomethasone HFA)
Completed
- Asthma
- salmeterol
- beclomethasone HFA
-
San Diego, California
- +6 more
Dec 26, 2017
Pulmonary Disease, Chronic Obstructive, Lung Diseases, Lung Diseases, Obstructive Trial in Worldwide (PF-00610355, PF -
Completed
- Pulmonary Disease, Chronic Obstructive
- +2 more
- PF-00610355
- +4 more
-
Fairhope, Alabama
- +74 more
Feb 1, 2019
Pulmonary Disease, Chronic Obstructive Trial in Manchester, London (GSK159802, Placebo, Salmeterol)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK159802
- +2 more
-
Manchester, Lancashire, United Kingdom
- +1 more
Sep 27, 2017
Pharmacokinetics in Healthy Young Men Trial in Copenhagen (Salmeterol)
Completed
- Pharmacokinetics in Healthy Young Men
- Salmeterol
-
Copenhagen, Select State, DenmarkBispebjerg Hospital
Jan 29, 2017
COPD Trial in Worldwide (Budesonide, Fluticasone, Indacaterol)
Completed
- Chronic Obstructive Pulmonary Disease
- Budesonide
- +3 more
-
Caba, Buenos Aires, Argentina
- +24 more
Apr 17, 2017
Pulmonary Disease, Chronic Obstructive Trial in United States (Salmeterol, Fluticasone Propionate/Salmeterol Combination
Terminated
- Pulmonary Disease, Chronic Obstructive
- Salmeterol
- Fluticasone Propionate/Salmeterol Combination Product
-
Birmingham, Alabama
- +10 more
Oct 27, 2016
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (salmeterol, tiotropium, GSK233705)
Completed
- Pulmonary Disease, Chronic Obstructive
- salmeterol
- +2 more
-
Helsinki, Finland
- +10 more
Oct 27, 2016
Pulmonary Disease, Chronic Obstructive Trial in Canada, United States (Salmeterol, Fluticasone Propionate/Salmeterol Combination
Completed
- Pulmonary Disease, Chronic Obstructive
- Salmeterol
- Fluticasone Propionate/Salmeterol Combination Product
-
Birmingham, Alabama
- +96 more
Oct 26, 2016
Pulmonary Disease, Chronic Obstructive Trial in Canada, United States (Fluticasone Propionate/Salmeterol Combination Product,
Completed
- Pulmonary Disease, Chronic Obstructive
- Fluticasone Propionate/Salmeterol Combination Product
- Salmeterol
-
Jasper, Alabama
- +109 more
Jan 19, 2017
COPD Trial in Ferrara (Salmeterol/Fluticasone combination, Salmeterol)
Completed
- Chronic Obstructive Pulmonary Disease
- Salmeterol/Fluticasone combination
- Salmeterol
-
Ferrara, ItalyResearch Centre on Asthma and COPD - Department of Clinical and
Apr 6, 2016
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK961081, Salmeterol, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- +2 more
-
Tallinn, Estonia
- +48 more
Nov 30, 2016
COPD Trial in Worldwide (carmoterol (CHF 4226), salmeterol, )
Completed
- Chronic Obstructive Pulmonary Disease
- carmoterol (CHF 4226)
- +2 more
-
Jonesboro, Arkansas
- +49 more
Apr 7, 2017